News

According to the American Association of Clinical Endocrinologists’ (AACE) approximately 1.2 million people in Texas are diagnosed with diabetes. Type 2 diabetes, the most common form of the

The application applies to the use of Rituxan (rituximab) in previously-untreated patients with intermediate grade or aggressive non-Hodgkin’s lymphoma. The treatment would be used in combination with anthracycline-based

Schering AG has been working with Cenix, a spin-off from the European Molecular Biology Laboratory and the Max Planck Institute, completing pilot studies using Cenix’s technology to seek

Production of influenza vaccine using cell-culture technology may offer advantages over traditional manufacturing methods by eliminating the dependence on chicken eggs for production. The removal of egg supply

Under the terms of the agreement, Siemens will offer its health system customers access to RxHub’s pithily titled ‘Medication and Eligibility Delivery Solution’ (MEDS). The system, essentially a

The pivotal 150-patient, multi-center trial was designed to evaluate the safety and efficacy of the fibrin sealant prepared by ThermoGenesis’s CryoSeal FS System as an adjunct to hemostasis

The study by University College London (UCL) and King’s College London suggests that in everyday life, schizophrenics take less account of visual context. If this is part of

The compound, OGX-011, is a second-generation antisense drug designed to specifically inhibit the production of clusterin, a cell-survival protein associated with resistance to standard anticancer treatments. The clinical

The two organizations will work together using Affymetrix’ GeneChip microarray technology and CureSearch Children’s Oncology Group’s (COG’s) existing databank of more than 20,000 tumor samples to discover and